Join BIOCYTOGEN at JPM Healthcare Conference 2025

Join BIOCYTOGEN at JPM Healthcare Conference 2025

We are pleased to announce our participation as an exhibitor at the JPM Healthcare Conference 2025, taking place from January 13th to 16th in San Francisco, CA. This prestigious event will convene leading professionals in life sciences to foster knowledge exchange, collaboration, and innovation. We look forward to engaging with industry leaders and advancing meaningful discussions about the future of healthcare. 

What is the JPM Healthcare Conference 2025?

This premier conference stands as the largest and most influential healthcare investment symposium in the industry, serving as a vital platform for fostering connections among global industry leaders, rapidly growing companies, and cutting-edge innovators in technology development. It also provides an unparalleled opportunity for engagement with key members of the investment community. By facilitating the exchange of insights, strategies, and groundbreaking ideas, the event plays a pivotal role in shaping the future of healthcare and biotechnology industries.

Event Overview  

Date: January 13th 9:00 am – 16th 5:50 pm

Venue: 335 Powell St, San Francisco, CA 94102

About BIOCYTOGEN

Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

We look forward to seeing you at the JPM Healthcare Conference 2025 in San Francisco, California!

Share:

Back to top
WordPress Double Opt-in by Forge12